These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3163055)

  • 1. Granulocyte adherence changes: an index of biocompatibility.
    Aljama P; Martin-Malo A; Garin JM; Torres A; Castillo D; Fuentes M; Gomez JM
    Kidney Int Suppl; 1988 Mar; 24():S68-72. PubMed ID: 3163055
    [No Abstract]   [Full Text] [Related]  

  • 2. Biocompatibility, leachables and membrane structure.
    Dorson WJ
    Trans Am Soc Artif Intern Organs; 1984; 30():715-7. PubMed ID: 6533969
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of different dialyzer membranes on plasma levels of granulocyte elastase.
    Hörl WH; Steinhauer HB; Riegel W; Schollmeyer P; Schäfer RM; Heidland A
    Kidney Int Suppl; 1988 Mar; 24():S90-1. PubMed ID: 3163062
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biocompatibility].
    Vanholder R
    Ned Tijdschr Geneeskd; 1988 Apr; 132(16):716-9. PubMed ID: 3287188
    [No Abstract]   [Full Text] [Related]  

  • 5. Extracorporeal thromboxane release and the morphological structure of artificial membrane after blood exposure.
    Mahiout A; Lajous-Peter AM; Jörres A; Meinhold H; Kessel M
    Kidney Int Suppl; 1988 Mar; 24():S75-9. PubMed ID: 3163057
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of membranes used in the treatment of end-stage renal failure.
    Hoenich NA; Stenton SC; Woffindin C; Levett D; Fawcett S; Quereshi M; Tapson JS; Ward MK
    Kidney Int Suppl; 1988 Mar; 24():S44-8. PubMed ID: 3163051
    [No Abstract]   [Full Text] [Related]  

  • 7. Complement activation by biomaterials.
    Johnson RJ
    Prog Clin Biol Res; 1990; 337():507-12. PubMed ID: 2353012
    [No Abstract]   [Full Text] [Related]  

  • 8. Biocompatibility and risk of infection in haemodialysis patients.
    Himmelfarb J; Hakim RM
    Nephrol Dial Transplant; 1994; 9 Suppl 2():138-44. PubMed ID: 8065605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical aspects of biocompatibility].
    Schiffl H; Lang SM; Keuneke C; Fricke H
    Wien Klin Wochenschr; 1996; 108 Suppl 1():4-8. PubMed ID: 8686323
    [No Abstract]   [Full Text] [Related]  

  • 10. Improvement of dialyzer compatibility by reduction of membrane surface area.
    Schaefer RM; Rautenberg W; Neumann S; Heidland A; Hörl WH
    Clin Nephrol; 1986; 26 Suppl 1():S35-8. PubMed ID: 3644705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Granulocyte hypersensitivity reactions in hemodialysis treatment].
    Kolb G
    Fortschr Med; 1993 Mar; 111(8):130-1. PubMed ID: 8509005
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pulmonary (side)effects of extracorporeal therapy procedures].
    Kolb G
    Wien Klin Wochenschr; 1996; 108 Suppl 1():15-20. PubMed ID: 8686322
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased soluble CD14 levels in patients on hemodialysis. Influence of dialysate endotoxin or incompatibility to dialyzer membranes?
    Mitzner S; Stange J; Pichel K; Handschuk I; Korten G; Ehlers M; Schutt C; Schmidt R
    ASAIO J; 1995; 41(3):M707-8. PubMed ID: 8573897
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte kinetics in burns.
    Asko-Seljavaara S
    J Burn Care Rehabil; 1987; 8(6):492-5. PubMed ID: 3325511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biocompatibility of hemodialysis using cuprophane membranes.
    Rommes JH; Sangster B; Borst C; Daha MR; van Heijst NP
    Vet Hum Toxicol; 1987 Aug; 29(4):293-9. PubMed ID: 3629907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research on dialyzers with improved biocompatibility.
    van der Steen A
    Clin Nephrol; 1986; 26 Suppl 1():S39-42. PubMed ID: 3829466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of the degree of deacetylation of chitosan on the biocompatibility of chitosan membrane with corneal stromal cells].
    Yao Z; Wu H; Han B; Liu W
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Aug; 23(4):800-4. PubMed ID: 17002111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of biocompatible membranes on neutrophil function and metabolism.
    Haag-Weber M; Hörl WH
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S31-6. PubMed ID: 7923981
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of platelet activating factor in hemodialysis.
    Tetta C; David S; Biancone L; Canino F; Cambi V; Camussi G
    Kidney Int Suppl; 1993 Jan; 39():S154-7. PubMed ID: 8468919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.